Linking risk factors and disease origins in breast cancer

November 20, 2013, Landes Bioscience

Researchers from the Geisel School of Medicine at Dartmouth have found that epigenetic changes to DNA are associated with aging in disease-free breast tissues and are further altered in breast tumors. Epigenetic changes describe heritable alterations caused by mechanisms other than by changes in DNA sequence. The discovery, published in the February 2014 issue of Epigenetics, illustrates how cancer and aging are tightly interconnected processes by identifying epigenetic alterations present in the normal aging breast that may increase disease risk in cancer-free individuals.

The examined highlight different patterns in DNA methylation, which involves the chemical modification of DNA and acts in the control of gene expression. While DNA methylation is a normal and necessary epigenetic process, exhibit altered methylation patterns compared to normal . Accordingly, atypical DNA methylation marks are recognized to precede cancer initiation.

For the study, the researchers leveraged publicly available genome-wide methylation data on disease-free breast tissues and identified consistent methylation alterations associated with the aging process across multiple populations. The levels of methylation in normal tissues were then compared to breast tumor tissues where age-related changes were further altered in breast tumors. Their data suggests that there may be common genomic regions that are particularly susceptible to changes in DNA methylation over time in disease-free breast tissue (or that these changes are selected for) on the path to development of cancer.

Although age is the strongest demographic risk factor for breast cancer, the mechanisms underlying how age increases a woman's risk for the development of disease are incompletely characterized. Emerging literature has demonstrated that aging can have profound effects on DNA methylation patterns that reflect an accumulation of exposures. Hence, the study extends the understanding of the biological mechanisms through which an established factor, such as age, contributes to carcinogenesis.

Explore further: Epigenetic silencing of the HAND2 tumor suppressor promotes endometrial cancer

More information: www.landesbioscience.com/journ … etics/article/27015/

Related Stories

Epigenetic silencing of the HAND2 tumor suppressor promotes endometrial cancer

November 12, 2013
A study published this week in PLOS Medicine suggests that epigenetic modification of the HAND2 gene plays a critical role in the development of endometrial cancer. HAND2 is active in the healthy endometrium (the tissue lining ...

DNA methylation level is marker of breast cancer risk

May 11, 2012
(HealthDay) -- Women with high levels of white blood cell (WBC) DNA methylation at the ATM loci have a significantly increased risk of breast cancer, regardless of family history or menopausal status, according a study published ...

Methylation linked to metabolic disease

November 11, 2013
(Medical Xpress)—In the first in-depth analysis of DNA methylation in fat, a process that affects the regulation of genes, researchers have linked regions of methylation to metabolic traits such as high body mass index ...

An epigenetic difference in twins explains different risk of breast cancer

October 17, 2012
Monozygotic twins have the same genome, that is, the same DNA molecule in both siblings. Despite being genetically identical, both twins may have different diseases at different times. This phenomenon is called "twin discordance". ...

Excess estrogen in pregnancy can silence BRCA1 in daughters, increasing breast cancer risk

April 9, 2013
Excess estrogen levels during pregnancy can disable, in their daughters, a powerful breast cancer tumor suppressor gene, say researchers at Georgetown Lombardi Comprehensive Cancer Center. They found the DNA repair gene BRCA1 ...

DNA changes during pregnancy persist into childhood

September 4, 2013
Even before they are born, babies accumulate changes in their DNA through a process called DNA methylation that may interfere with gene expression, and in turn, their health as they grow up. But until now it's been unclear ...

Recommended for you

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

Biologists discover how pancreatic tumors lead to weight loss

June 20, 2018
Patients with pancreatic cancer usually experience significant weight loss, which can begin very early in the disease. A new study from MIT and Dana-Farber Cancer Institute offers insight into how this happens, and suggests ...

Researchers find 11 genes responsible for the spread of cancer

June 20, 2018
A groundbreaking discovery by University of Alberta researchers has identified previously-unknown therapeutic targets that could be key to preventing the spread of cancer.

'Kiss of death' cancer: How computational geeks may have uncovered a therapy for a deadly disease

June 19, 2018
It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negative breast cancer is aggressive and deadly. Patients ...

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Team discovers gene mutations linked to pancreatic cancer

June 19, 2018
Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.